Long-term outcome of patients with alpha-mannosidosis – A single center study

Introduction: Alpha-mannosidosis (AM) is a rare autosomal recessive lysosomal storage disease which the natural history has not been exhaustively described yet. The aim of this study was to present the long-term follow-up of 12 Polish patients with AM, evaluate the clinical, biochemical, and molecul...

Full description

Bibliographic Details
Main Authors: Patryk Lipiński, Agnieszka Różdżyńska-Świątkowska, Katarzyna Iwanicka-Pronicka, Barbara Perkowska, Paulina Pokora, Anna Tylki-Szymańska
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221442692100121X
_version_ 1818331961994772480
author Patryk Lipiński
Agnieszka Różdżyńska-Świątkowska
Katarzyna Iwanicka-Pronicka
Barbara Perkowska
Paulina Pokora
Anna Tylki-Szymańska
author_facet Patryk Lipiński
Agnieszka Różdżyńska-Świątkowska
Katarzyna Iwanicka-Pronicka
Barbara Perkowska
Paulina Pokora
Anna Tylki-Szymańska
author_sort Patryk Lipiński
collection DOAJ
description Introduction: Alpha-mannosidosis (AM) is a rare autosomal recessive lysosomal storage disease which the natural history has not been exhaustively described yet. The aim of this study was to present the long-term follow-up of 12 Polish patients with AM, evaluate the clinical, biochemical, and molecular findings and progression of the disease. Material and methods: The article presents a long-term (over 30 years) observational, retrospective, single-center study of patients with AM. Results: The hearing loss, as one of the first symptoms, was detected in childhood (mean age of 2 years and 6 months) in 10 patients. The other symptoms include: recurrent infections (all patients), inguinal hernias (6 patients), craniosynostosis (1 patient). The mean age at AM diagnosis was 6 years while median was 4 years (age range: 1 year and 8 months – 12 years). The most commonly identified variant in the MAN2B1 gene was c.2245C > T, p.(Arg749Trp). The mean time of follow-up in our study was approximately 14years (range: 1 year – 26 years). Following birth, children with AM grow slowly, finally reaching the 3rd percentile (or values below the 3rd percentile). Hearing loss was not progressive while a gradual exacerbation of intellectual disability with no developmental regression was observed in all patients. Ataxia was diagnosed in 6 patients in the second decade of life (age range 15–20 years). Conclusions: Our study revealed the sensorineural hearing loss as one of the first noted symptom in AM which was congenital and non-progressive during the natural course of disease. A detailed anthropometric phenotype of AM patients was provided with observation of the growth decline during the long-term follow-up. Our study confirmed the existence of two distinguished clinical phenotypes of AM (mild and moderate), and also the lack of clear genotype-phenotype correlation.
first_indexed 2024-12-13T13:28:10Z
format Article
id doaj.art-09b992e8f94b44fba03e6663511a659e
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-12-13T13:28:10Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-09b992e8f94b44fba03e6663511a659e2022-12-21T23:44:14ZengElsevierMolecular Genetics and Metabolism Reports2214-42692022-03-0130100826Long-term outcome of patients with alpha-mannosidosis – A single center studyPatryk Lipiński0Agnieszka Różdżyńska-Świątkowska1Katarzyna Iwanicka-Pronicka2Barbara Perkowska3Paulina Pokora4Anna Tylki-Szymańska5Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, PolandAnthropology Laboratory, The Children's Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Audiology and Phoniatry, The Children's Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, Poland; Corresponding author at: Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland.Introduction: Alpha-mannosidosis (AM) is a rare autosomal recessive lysosomal storage disease which the natural history has not been exhaustively described yet. The aim of this study was to present the long-term follow-up of 12 Polish patients with AM, evaluate the clinical, biochemical, and molecular findings and progression of the disease. Material and methods: The article presents a long-term (over 30 years) observational, retrospective, single-center study of patients with AM. Results: The hearing loss, as one of the first symptoms, was detected in childhood (mean age of 2 years and 6 months) in 10 patients. The other symptoms include: recurrent infections (all patients), inguinal hernias (6 patients), craniosynostosis (1 patient). The mean age at AM diagnosis was 6 years while median was 4 years (age range: 1 year and 8 months – 12 years). The most commonly identified variant in the MAN2B1 gene was c.2245C > T, p.(Arg749Trp). The mean time of follow-up in our study was approximately 14years (range: 1 year – 26 years). Following birth, children with AM grow slowly, finally reaching the 3rd percentile (or values below the 3rd percentile). Hearing loss was not progressive while a gradual exacerbation of intellectual disability with no developmental regression was observed in all patients. Ataxia was diagnosed in 6 patients in the second decade of life (age range 15–20 years). Conclusions: Our study revealed the sensorineural hearing loss as one of the first noted symptom in AM which was congenital and non-progressive during the natural course of disease. A detailed anthropometric phenotype of AM patients was provided with observation of the growth decline during the long-term follow-up. Our study confirmed the existence of two distinguished clinical phenotypes of AM (mild and moderate), and also the lack of clear genotype-phenotype correlation.http://www.sciencedirect.com/science/article/pii/S221442692100121Xalpha-MannosidosisLysosomal storage diseaseMAN2B1 geneCongenital sensorineural hearing lossGrowth decline
spellingShingle Patryk Lipiński
Agnieszka Różdżyńska-Świątkowska
Katarzyna Iwanicka-Pronicka
Barbara Perkowska
Paulina Pokora
Anna Tylki-Szymańska
Long-term outcome of patients with alpha-mannosidosis – A single center study
Molecular Genetics and Metabolism Reports
alpha-Mannosidosis
Lysosomal storage disease
MAN2B1 gene
Congenital sensorineural hearing loss
Growth decline
title Long-term outcome of patients with alpha-mannosidosis – A single center study
title_full Long-term outcome of patients with alpha-mannosidosis – A single center study
title_fullStr Long-term outcome of patients with alpha-mannosidosis – A single center study
title_full_unstemmed Long-term outcome of patients with alpha-mannosidosis – A single center study
title_short Long-term outcome of patients with alpha-mannosidosis – A single center study
title_sort long term outcome of patients with alpha mannosidosis a single center study
topic alpha-Mannosidosis
Lysosomal storage disease
MAN2B1 gene
Congenital sensorineural hearing loss
Growth decline
url http://www.sciencedirect.com/science/article/pii/S221442692100121X
work_keys_str_mv AT patryklipinski longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy
AT agnieszkarozdzynskaswiatkowska longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy
AT katarzynaiwanickapronicka longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy
AT barbaraperkowska longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy
AT paulinapokora longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy
AT annatylkiszymanska longtermoutcomeofpatientswithalphamannosidosisasinglecenterstudy